基于临床参数和[18F]-FDG PET/CT的新诊断多发性骨髓瘤患者预后预测系统
本研究回顾性分析133例新诊断多发性骨髓瘤(NDMM)患者的临床数据与PET/CT参数,确定无进展生存期(PFS)和总生存期(OS)的独立预测因素,并构建新的预后预测系统(NPPS)。结果显示SUVmax、血清游离轻链(sFLC)比值和髓外病变(EMD)是PFS和OS的独立预测因素,基于这三项指标的NPPS能有效预测OS,且预后区分效果优于ISS、R-ISS和R2-ISS。
要点
- SUVmax、sFLC比值和EMD是新诊断多发性骨髓瘤患者PFS和OS的独立预测因素。
- 基于SUVmax、sFLC比值和EMD构建的NPPS能有效预测OS。
- NPPS的预后区分效果优于ISS、R-ISS和R2-ISS。
核心结论
- [18F]-FDG PET/CT参数在新诊断多发性骨髓瘤患者预后预测中起重要作用。
- 基于SUVmax、sFLC比值和EMD的NPPS在预后区分上优于ISS、R-ISS和R2-ISS。
研究设计与样本
- 回顾性分析133例新诊断多发性骨髓瘤患者的临床数据和PET/CT参数。
- 分析临床指标与PET/CT参数之间的关联,确定PFS和OS的独立预测因素。
- 基于研究结果构建新的预后预测系统(NPPS),并比较NPPS、ISS、R-ISS和R2-ISS的预测效果。
主要发现
- SUVmax较高(≥5.3)的患者中,β2微球蛋白、血清肌酐(sCr)、血清钙(sCa)和C反应蛋白升高的患病率更高。
- 局灶性病变数量较多(≥10)的患者中,sCa升高、sCr升高和髓外病变(EMD)的患病率更高。
- SUVmax、血清游离轻链(sFLC)比值和EMD是PFS和OS的独立预测因素。
- NPPS使用SUVmax、sFLC比值和EMD能有效预测OS,且预后区分效果优于ISS、R-ISS和R2-ISS。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to assess prognosis of patients with newly diagnosed multiple myeloma (NDMM) by combining [18F]-FDG positron emission tomography (PET)/CT parameters and clinical indices. METHODS: Clinical data and PET/CT parameters of 133 NDMM patients were retrospectively analyzed for associations between clinical indices and PET/CT parameters. Independent predictors of progression-free survival (PFS) and overall survival (OS) were determined. A new prognostic prediction system (NPPS) was constructed based on our findings. Prediction effectiveness was compared among the NPPS, International Staging System (ISS), Revised ISS (R-ISS), and R2-ISS. RESULTS: Prevalence of elevated β2-microglobulin, serum creatinine (sCr), serum calcium (sCa), and C-reactive protein concentrations was higher in patients with higher SUVmax (≥ 5.3). Prevalence of elevated sCa, sCr, and extramedullary disease (EMD) was higher in patients with a higher number of focal lesions (≥ 10). SUVmax, serum free-light chain (sFLC) ratio, and EMD were independent predictors of PFS and OS. The NPPS used SUVmax, sFLC ratio, and EMD could effectively predict OS and was more effective at prognostication than the ISS, R-ISS, and R2-ISS. CONCLUSIONS: [18F]-FDG PET/CT parameters play a significant role in predicting prognosis in NDMM patients. The NPPS based on SUVmax, sFLC ratio, and EMD outperformed the ISS, R-ISS, and R2-ISS in prognostication.
引用
- Li J, Zhang X, Qin C, et al. A prognostication system based on clinical parameters and [18F]-FDG PET/CT in patients with newly diagnosed multiple myeloma. Eur J Nucl Med Mol Imaging. 2022. PMID: 36576511. doi:10.1007/s00259-022-06088-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。